Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: The Losartan Intervention for Endpoint Reduction in Hypertension study

Journal of Hypertension

Volumn 26, Issue 6, 2008, Pages 1244-1249

  Li, Zhibin ^a   Dahlöf, Björn ^b   Okin, Peter M ^a   Kjeldsen, Sverre E ^c   Wachtell, Kristian ^d   Ibsen, Hans ^d   Nieminen, Markku S ^e   Jern, Sverker ^b   Devereux, Richard B ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF OSLO   (Norway)

^d GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cardiovascular morbidity and mortality; Hypertension; Left bundle branch block; Left ventricular hypertrophy

Indexed keywords

ATENOLOL; LOSARTAN; PLACEBO;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; STATISTICAL SIGNIFICANCE;

EID: 43449115099     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282fcc23c     Document Type: Article

References (19)